IDH1 and glioma: Moreover, further studies have shown that IDH mutant gliomas exhibit lower numbers of CD3+ and CD8+ lymphocytes in the tumor milieu because of the reduced T-cell expression, attracting the chemokines CXCL9 and CXCL10 and their regulator, STAT1 [88].